About us

European knowledge base for researchers and industry

Nanomaterials developed for medical application are of broad range. Due to the complex nature of different nanomaterials, their characterization is often proven to be extensive and obscure for developers. However, to respond to the requirements of the regulatory agencies before new nanomaterials get approved, the extensive characterization of the nanomaterial is needed. To achieve this, the EUNCL was established as a decentralised institution composed of multiple European key reference centers combining diverse core competences in one unique service center.

The EUNCL has a strong partnership with the USNCL which was founded in 2004 by the NCI (National Cancer Institute, Frederick, USA) to accelerate development of promising nanotech therapies and diagnostics. Based on this expertise the EUNCL developed an "Assay cascade" for new nanomaterials which covers the physical and chemical characterization (PCC) as well as in vitro and in vivo biological properties. This set of assays allows a full characterization for nanomaterials free-of-charge.

The aim of EUNCL is to provide state-of-the-art pre-clinical characterization of innovative nanomaterials in order to accelerate their development towards the regulatory approval by the European Medicines Agency (EMA) and the national agencies. Additionally, product developers (public laboratories, spin-offs and SMEs) are guided through this process by the efficient management team unifying expertise from internal and external experts. As a result, the EUNCL serve as a European resource and knowledge base for researchers and industry to guide and facilitate the regulatory review of new nanomaterials, which will accelerate the transition of innovative nanomaterials into medical applications.

Events where you meet EUNCL

More Events ...

European Nanomedicine Characterisation Laboratory (EUNCL)

Call for Proposals!

News

  • Last General Assembly met in Stoos, Switzerland 23. - 24. May 2019
    The project’s last General Assembly took place under the motto ‘overview, impact and forecast’. The Work Package leader presented a pre-final report on their respective WPs, recapitulating the tasks accomplished during the last 3,5 years of the project’s runtime.
  • NCI-NCL – Open position
    The NCL is looking for an experienced analytical chemist to add to our team.
  • EUNCL ExBo Meeting in Liverpool
    The EUNCL ExBo met on 22nd and 23rd November 2018 at University of Liverpool to discuss the actual status of the work in the project and especially in the TNA. The CET and TNA management updated the ExBo on the on-going and the further work planned. The discussion on all questions raised during the meeting was very extensive and important decisions were taken for the last year of the project duration.

More News ...